PRIVACY ALERT: AWKO Law LLP Investigates Quest Diagnostics for Data Breach of Patient Records
PRIVACY ALERT: AWKO Law LLP Investigates Quest Diagnostics for Data Breach of Patient Records
AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of patients of Quest Diagnostics, a New Jersey-based diagnostic testing company.
Quest Diagnostics disclosed in its Securities and Exchange Commission (“SEC”) Form 8-K filing that on October 21, 2026, it identified unauthorized activity in its Quanum Lab Services Manager, a platform where certain clients can place test orders and receive or look up their results. Quest Diagnostics has not disclosed the number of individuals impacted.
Although the breach occurred in October 2026, Quest Diagnostics has not yet directly notified impacted individuals, which may have violated state and federal laws. The following data may have been compromised in the breach: patient records.
If your personal information was impacted by this incident, you may be at risk of identity theft and other serious violations of your privacy. As a result, you may be entitled to money damages and an injunction requiring changes to Quest Diagnostics’ cybersecurity practices.
If you received notification of this data breach or are a patient of Quest Diagnostics and wish to obtain additional information about your legal rights, please contact us today at (415) 251-6804 or sdixit@awkolawllp.com.
(415) 251-6804
sdixit@awkolawllp.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261023208013/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
5 Stocks to Buy Trading at Big Discounts
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
United States